HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effectiveness of lenalidomide (Revlimid) for the treatment of plasma cell leukemia.

AuthorsDon M Benson Jr, Megan K Smith
JournalLeukemia & lymphoma (Leuk Lymphoma) Vol. 48 Issue 7 Pg. 1423-5 (Jul 2007) ISSN: 1042-8194 [Print] United States
PMID17613775 (Publication Type: Case Reports, Letter, Comment)
Chemical References
  • Thalidomide
  • Lenalidomide
Topics
  • Female
  • Humans
  • Kinetics
  • Lenalidomide
  • Leukemia, Plasma Cell (diagnosis, drug therapy)
  • Middle Aged
  • Thalidomide (analogs & derivatives, therapeutic use)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: